Top compounds associated with response to ADGRD1


Feature Type Standardized
Nominal ANOVA
mRNA tivozanib CTRPv2 pan-cancer AAC -0.033 0.4
mRNA tosedostat CTRPv2 pan-cancer AAC -0.023 0.5
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.037 0.3
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.0056 0.9
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC -0.028 0.3
mRNA trifluoperazine CTRPv2 pan-cancer AAC -0.016 0.7
mRNA triptolide CTRPv2 pan-cancer AAC -0.013 0.7
mRNA tubastatin A GDSC1000 pan-cancer AAC 0.053 0.07
mRNA tubastatin A CTRPv2 pan-cancer AAC -0.041 0.4
mRNA valdecoxib CTRPv2 pan-cancer AAC 0.031 0.4
Download CSV